93 related articles for article (PubMed ID: 3516482)
1. Disturbances of prostacyclin metabolism in children with hemolytic-uremic syndrome and in first degree relatives.
Túri S; Beattie TJ; Belch JJ; Murphy AV
Clin Nephrol; 1986 Apr; 25(4):193-8. PubMed ID: 3516482
[TBL] [Abstract][Full Text] [Related]
2. Reversible deficient prostacyclin release in childhood hemolytic uremic syndrome.
Chamone DA; Proesmans WC; Monnens LA; Binda ki Muaka P; Vermylen JG
Int J Pediatr Nephrol; 1982 Mar; 3(1):13-6. PubMed ID: 7049977
[TBL] [Abstract][Full Text] [Related]
3. 6-keto-PGF1 alpha levels and prostacyclin therapy in 2 adult patients with hemolytic-uremic syndrome.
Hautekeete ML; Nagler JM; Cuykens JJ; Parizel G; Laekeman GM; Herman AG
Clin Nephrol; 1986 Sep; 26(3):157-9. PubMed ID: 3533335
[TBL] [Abstract][Full Text] [Related]
4. Plasma exchanges in frequently recurrent hemolytic-uremic syndrome in a child.
Feldhoff CM; Luboldt W; Bussmann K; Schrör K
Int J Pediatr Nephrol; 1983 Dec; 4(4):239-42. PubMed ID: 6363316
[TBL] [Abstract][Full Text] [Related]
5. Abnormal prostacyclin metabolism in the hemolytic uremic syndrome: equivocal effect of prostacyclin infusions.
Defreyn G; Proesmans W; Machin SJ; Lemmens F; Vermylen J
Clin Nephrol; 1982 Jul; 18(1):43-9. PubMed ID: 6749362
[TBL] [Abstract][Full Text] [Related]
6. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
7. Renal prostacyclin biosynthesis is reduced in children with hemolytic-uremic syndrome in the context of systemic platelet activation.
Noris M; Benigni A; Siegler R; Gaspari F; Casiraghi F; Mancini ML; Remuzzi G
Am J Kidney Dis; 1992 Aug; 20(2):144-9. PubMed ID: 1496967
[TBL] [Abstract][Full Text] [Related]
8. Hemolytic uremic syndrome in three adult siblings: a familial study and evolution.
Pirson Y; Lefebvre C; Arnout C; van Ypersele de Strihou C
Clin Nephrol; 1987 Nov; 28(5):250-5. PubMed ID: 3480783
[TBL] [Abstract][Full Text] [Related]
9. Intraplatelet serotonin (I5HT) in children with the hemolytic uremic syndrome.
Edefonti A; Bettinelli A; Mondonico P; Claris Appiani A; Picca M; Cossu MM; Tentori F; Giani M; Rossi E
Clin Nephrol; 1985 Apr; 23(4):207-11. PubMed ID: 4006329
[TBL] [Abstract][Full Text] [Related]
10. Reduced platelet aggregation in hemolytic-uremic syndrome.
Kaplan BS; Fong JS
Thromb Haemost; 1980 Jun; 43(2):154-7. PubMed ID: 7455975
[TBL] [Abstract][Full Text] [Related]
11. Elevated tissue factor circulating levels in children with hemolytic uremic syndrome caused by verotoxin-producing E. coli.
Kamitsuji H; Nonami K; Murakami T; Ishikawa N; Nakayama A; Umeki Y
Clin Nephrol; 2000 May; 53(5):319-24. PubMed ID: 11305804
[TBL] [Abstract][Full Text] [Related]
12. Hemolytic-uremic syndrome (HUS): a clinicopathological study of 15 cases.
Tinaztepe K; Akkök N; Tinaztepe B
Turk J Pediatr; 1993; 35(1):23-36. PubMed ID: 8236514
[TBL] [Abstract][Full Text] [Related]
13. Short-term and long-term outcome of hemolytic uremic syndrome in Iranian children.
Otukesh H; Hoseini R; Golnari P; Fereshtehnejad SM; Zamanfar D; Hooman N; Tabarroki A
J Nephrol; 2008; 21(5):694-703. PubMed ID: 18949724
[TBL] [Abstract][Full Text] [Related]
14. [Uremic and haemolytic syndrome in children: study of 17 cases].
Chemli J; Hassayoun S; Krid S; Ghali N; Abroug S; Zakhama A; Harbi A
Tunis Med; 2008 May; 86(5):479-85. PubMed ID: 19469304
[TBL] [Abstract][Full Text] [Related]
15. Prostacyclin production following in vitro mixing of normal with hemolytic-uremic-syndrome serum.
Siegler RL; Smith JB; Lynch MB; Mohammad SF
West J Med; 1988 Jul; 149(1):37-9. PubMed ID: 3043896
[TBL] [Abstract][Full Text] [Related]
16. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.
Fremeaux-Bacchi V; Moulton EA; Kavanagh D; Dragon-Durey MA; Blouin J; Caudy A; Arzouk N; Cleper R; Francois M; Guest G; Pourrat J; Seligman R; Fridman WH; Loirat C; Atkinson JP
J Am Soc Nephrol; 2006 Jul; 17(7):2017-25. PubMed ID: 16762990
[TBL] [Abstract][Full Text] [Related]
17. Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections.
Artz MA; Steenbergen EJ; Hoitsma AJ; Monnens LA; Wetzels JF
Transplantation; 2003 Sep; 76(5):821-6. PubMed ID: 14501861
[TBL] [Abstract][Full Text] [Related]
18. Albuminuria and estimated GFR 5 years after Escherichia coli O157 hemolytic uremic syndrome: an update.
Garg AX; Salvadori M; Okell JM; Thiessen-Philbrook HR; Suri RS; Filler G; Moist L; Matsell D; Clark WF
Am J Kidney Dis; 2008 Mar; 51(3):435-44. PubMed ID: 18295059
[TBL] [Abstract][Full Text] [Related]
19. [Prostacyclin metabolism disorders in the hemolytic uremia syndrome in the blood of children and members of their family].
Túri S; Beattie TJ; Belch JF; Murphy AM
Orv Hetil; 1986 Jan; 127(2):69-75. PubMed ID: 3511430
[No Abstract] [Full Text] [Related]
20. Absence of plasma prostacyclin stimulating activity deficiency in hemolytic uremic syndrome.
Schlegel N; Maclouf J; Loirat C; Drouet L; Marotte R; Scarabin PY; Mathieu H
J Pediatr; 1987 Jul; 111(1):71-7. PubMed ID: 3298597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
